Agenda

• Why Hasn’t Endocardial Ablation of the LAPW Demonstrated Benefit Over PVI?

Randall Lee, MD – University of California, San Francisco, USA, AtriCure

• Is Repeat Catheter Ablation Delaying Definitive Therapy?

Syed Ahsan, MD – Bart’s Heart Centre, London, UK

• Is PFA Effective in the Treatment of Persistent and Long-Standing Persistent Atrial Fibrillation?

Nitesh Sood, MD – Southcoast Health, Fallriver, USA

• Comparative Survival Outcomes of Hybrid and Catheter Ablations: Analysis of Individual TimeTo-Event Data

Riyaz Kaba, MD – St George’s Hospital, London, UK

• Q&A Open Session With Panelists

• From Paroxysmal to Advanced Substrate: Hybrid Ablation for Advanced AF in Heart Failure Patients

• Changes in Cardiac Mechanics After Hybrid AF Ablation

Carlo De Asmundis, MD – UZ Brussels, Belgium

• All in 1: Convergent Ablation, LAA Exclusion and Endocardial PFA Ablation

John Yap, MD – Bart’s Heart Centre, London, UK

Syed Ahsan, MD – Bart’s Heart Centre, London, UK

• All in 1 : Convergent Ablation, LAA Exclusion and MIDCAB

Christian Carranza, MD – Rigshospitalet, Copenhagen, Denmark

• Which Patients and When? Should Hybrid Be Considered Earlier?

Panel Discussion

• Q& A Open Session With Panelists

• Importance of Critical Mass and Epicardial LAA Exclusion

Devi Nair, MD – St. Bernard’s Heart & Vascular Center Jonesboro, USA

• Long Term Durability Matters - CEASE-AF 3 Year Results

Timo Weimar, MD – Cardiac Surgeon, Stuttgart, Germany, AtriCure

• Evolution of TT-ABC (All Box Clamp) Technique

Nicolas Nikolaidis, MD – New Cross Hospital, Wolverhampton, UK

• Sinus Node Sparing for the Treatment of IST

Mark La Meir, MD – UZ Brussels, Belgium

• Future Directions in Hybrid AF Therapies / Q&A

Panel Discussion